ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00793572
Brief Title: Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

First Submitted : November 18, 2008
First Submitted that Met QC Criteria : November 18, 2008
First Posted : November 19, 2008 (Estimate)

Results First Submitted : April 11, 2017
Results First Submitted that Met QC Criteria : April 11, 2017
Results First Posted : May 18, 2017

Last Update Submitted that Met QC Criteria : May 30, 2017
Last Update Posted : June 23, 2017